The Mulder Lab focuses on the development, evaluation and translation of precision imaging and nanoimmunotherapy approaches in cardiovascular disease, cancer and transplantation. The ‘research ecosystem’ spans from the Nanomedicine Group at the Icahn School of Medicine at Mount Sinai in New York to the Precision Medicine Group at the Eindhoven University of Technology in The Netherlands and many collaborators.
For more than half a decade, we worked hard on trialing a nanoimmunotherapy in large cardiovascular disease animal models. The results of this work were published in Science Translational Medicine.
In the July issue of Nature Reviews Drug Discovery, we published a Perspective on 'Therapeutic targeting of trained immunity'. Our article was prominently highlighted on the cover.
We are very excited about our Immunity paper. It details the development and application of a nano-immunotherapy in transplantation.
The Missing Link in Organ Transplantation, a preview about our work.
'Behind the paper' by Marnix
We are very excited about our Nature Biomedical Engineering paper. It describes the development of a nano-immunotherapy and its evaluation in atherosclerotic mice and non-human primates.